-
-
-
-
-
-
-
Virax Biolabs Group (VRAX) Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes
-
-
-
-
-
-
-
Virax Biolabs' (VRAX) CEO Issues Letter to Shareholders
-
-
-
-
-
-
-
Cosmos Health (COSM) Holds EU Distribution Rights for Virax Biolabs’ Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits
-
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

